Cargando…
Post-Treatment Neutrophil and Lymphocyte Counts Predict Progression-Free Survival Following First-Line Chemotherapy in Hodgkin’s Lymphoma
Hodgkin’s lymphoma carries an excellent prognosis with modern chemotherapy, but a significant proportion of patients remain refractory to or relapse after first-line treatment. Immunological changes post-treatment, such as chemotherapy-induced neutropenia (CIN) or lymphopenia, have shown prognostic...
Autores principales: | Tan, Grace Fangmin, Goh, Siting, Chang, Esther Wei Yin, Tan, Ya Hwee, Chiang, Jianbang, Yang, Valerie Shiwen, Poon, Eileen Yi Ling, Somasundaram, Nagavalli, Bin Harunal Rashid, Mohamad Farid, Tao, Miriam, Lim, Soon Thye, Ong, Choon Kiat, Chan, Jason Yongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944084/ https://www.ncbi.nlm.nih.gov/pubmed/36810555 http://dx.doi.org/10.3390/hematolrep15010012 |
Ejemplares similares
-
A Prognostic Model Using Post-Steroid Neutrophil-Lymphocyte Ratio Predicts Overall Survival in Primary Central Nervous System Lymphoma
por: Lo, Yu Tung, et al.
Publicado: (2022) -
Treatment Outcomes and Survival Patterns of Asian Patients With Relapsed/Refractory Mantle Cell Lymphoma
por: Tan, Jing Yuan, et al.
Publicado: (2021) -
Pathogenesis and biomarkers of natural killer T cell lymphoma (NKTL)
por: Somasundaram, Nagavalli, et al.
Publicado: (2019) -
Clinical Features of Plasmablastic Lymphoma: Case Series From an Asian Tertiary Cancer Center and Literature Review
por: Yap, Daniel Ren Yi, et al.
Publicado: (2020) -
Evolving therapeutic landscape of diffuse large B-cell lymphoma: challenges and aspirations
por: Chan, Jason Yongsheng, et al.
Publicado: (2023)